| 000 | 02589 a2200661 4500 | ||
|---|---|---|---|
| 005 | 20250517031338.0 | ||
| 264 | 0 | _c20150825 | |
| 008 | 201508s 0 0 eng d | ||
| 022 | _a1090-2422 | ||
| 024 | 7 |
_a10.1016/j.yexcr.2015.04.016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFan, Zhongqi | |
| 245 | 0 | 0 |
_aABT737 enhances cholangiocarcinoma sensitivity to cisplatin through regulation of mitochondrial dynamics. _h[electronic resource] |
| 260 |
_bExperimental cell research _cJul 2015 |
||
| 300 |
_a68-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBile Duct Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aBile Ducts, Intrahepatic |
| 650 | 0 | 4 |
_aBiphenyl Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCholangiocarcinoma _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 | _aDynamins |
| 650 | 0 | 4 |
_aGTP Phosphohydrolases _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMembrane Proteins _xmetabolism |
| 650 | 0 | 4 |
_aMembrane Transport Proteins _xmetabolism |
| 650 | 0 | 4 |
_aMicrotubule-Associated Proteins _xmetabolism |
| 650 | 0 | 4 |
_aMitochondria _xmetabolism |
| 650 | 0 | 4 |
_aMitochondrial Dynamics _xdrug effects |
| 650 | 0 | 4 | _aMitochondrial Precursor Protein Import Complex Proteins |
| 650 | 0 | 4 |
_aMitochondrial Proteins _xmetabolism |
| 650 | 0 | 4 |
_aMitophagy _xdrug effects |
| 650 | 0 | 4 |
_aMyeloid Cell Leukemia Sequence 1 Protein _xbiosynthesis |
| 650 | 0 | 4 |
_aNitrophenols _xadministration & dosage |
| 650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
| 650 | 0 | 4 |
_aRNA-Binding Proteins _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xmetabolism |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 650 | 0 | 4 |
_abcl-2 Homologous Antagonist-Killer Protein _xbiosynthesis |
| 700 | 1 | _aYu, Huimei | |
| 700 | 1 | _aCui, Ni | |
| 700 | 1 | _aKong, Xianggui | |
| 700 | 1 | _aLiu, Xiaomin | |
| 700 | 1 | _aChang, Yulei | |
| 700 | 1 | _aWu, Yao | |
| 700 | 1 | _aSun, Liankun | |
| 700 | 1 | _aWang, Guangyi | |
| 773 | 0 |
_tExperimental cell research _gvol. 335 _gno. 1 _gp. 68-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.yexcr.2015.04.016 _zAvailable from publisher's website |
| 999 |
_c24864302 _d24864302 |
||